Cargando…
Antiviral T‐cell therapy
Serious viral infections are a common cause of morbidity and mortality after allogeneic stem cell transplantation. They occur in the majority of allograft recipients and are fatal in 17–20%. These severe infections may be prolonged or recurrent and add substantially to the cost, both human and finan...
Autores principales: | Leen, Ann M., Heslop, Helen E., Brenner, Malcolm K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927231/ https://www.ncbi.nlm.nih.gov/pubmed/24517423 http://dx.doi.org/10.1111/imr.12138 |
Ejemplares similares
-
The great balancing act: regulation and fate of antiviral T‐cell interactions
por: Moseman, E. Ashley, et al.
Publicado: (2013) -
Functional foods with antiviral activity
por: Kim, Da Hyun, et al.
Publicado: (2022) -
Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID‐19
por: Burton, Alice R., et al.
Publicado: (2021) -
US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection
por: Lee, Sungjin, et al.
Publicado: (2017) -
Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis
por: Chuang, Hong-Meng, et al.
Publicado: (2021)